Sohm said that the strategic alliance with the manufacturing house currently has a range of 85 products covering major therapeutic categories and marketing within the northern region of India.
Reportedly, Sohm India is expected to utilise 100% of the manufacturing capacity of the manufacturing house along with its own capacity. Sohm India will take over the existing 85 products of the manufacturing unit and private label and market them under the banner of Sohm India and Sohm US.
Shailesh Shah, vice president of corporate strategy at Sohm, said: “The manufacturing house facilities can produce all essential products in the dosage forms including tablets, capsules and oral liquids with excellent packing facilities.
“This will allow Sohm India to fulfill our growing market demand in the coming season and achieve the manufacturing volume growth needed to fulfill purchase orders. Himachal Pradesh is an area which is declared a tax exempt area by the government of India and this will help to reduce operating costs by almost 6% and increase profitability.”